Biotech software: from DIY to off the shelf
26 June, 2002 by Pete YoungThe task of creating specialised software tools to decipher the complexities of genes and proteins until recently has been a do-it-yourself project for the bio-research community.
Play to your strengths, says IBM's Kovac
26 June, 2002 by Iain ScottCaroline Kovac, the US-based business leader of IBM's Life Sciences division, says Australian biotechnology should remember it is playing in a global market and consider its strengths, including a good education system and strong scientific base.
Capillary Electrophoresis: choosing your machine
24 June, 2002 by Melissa TrudingerSample capacity is at the heart of the decision on what capillary electrophoresis system best fits a lab's needs.
Study: genomics equipment market worth $US2bn by 2007
24 June, 2002 by Iain ScottThe worldwide market for genomics equipment and services used to accelerate drug discovery and development is forecasted to increase from $US987 million this year to more than $US2 billion in 2007, according to a new study by US company Front Line Strategic Consulting.
WA proteomics firm finds Asia welcoming
20 June, 2002 by Pete YoungSingapore is rolling out a warm welcome to Australian expertise in protein biochemistry, according to West Australian company Proteomics International.
Iatia releases software package for imaging
19 June, 2002 by Tanya HollisA software package enabling users of electron microscopes to glean specialised information from their specimens is the second product to be released by newly listed vision sciences company Iatia.
Bioinformatics C of E interim board named
17 June, 2002 by Tanya HollisPlans for Tasmania's Bioinformatics Centre of Excellence are stepping up with the naming of its interim board.
The national synchrotron: ray of hope or ring of fire?
17 June, 2002 by Tanya HollisWhen the Victorian Government derailed the national synchrotron bidding process by announcing in June 2001 it would go it alone, it caught many people off guard.
Garvan appoints BioLateral to help set up bio-IT division
13 June, 2002 by Tanya HollisSydney bio-IT company BioLateral has won a three-month contract to help the Garvan Institute of Medical Research establish its $1 million Peter Wills Centre for Bioinformatics.
Promics gets VC vote of confidence
12 June, 2002 by Pete YoungDrug discovery company Promics has received a $2.5 million vote of confidence in its anti-inflammatory candidate PMX 53 from venture capital backers.
Icelandic genome map released
11 June, 2002 by Melissa TrudingerIcelandic company deCODE Genetics has updated the map of the human genome, estimated to give about five-fold greater resolution than the current draft.
Protein gel offers hope to childless
07 June, 2002 by Tanya HollisA pre-intercourse gel derived from a protein found in sperm could prove the key to fertility for thousands of childless couples.
Proteome Systems launches ProteomIQ, moves into Japan
03 June, 2002 by Iain ScottSydney-based company Proteome Systems' proteomics R&D system, ProteomIQ, has been launched on the market.
Intelligent Island sets priorities
29 May, 2002 by Pete YoungA head-hunting expedition to find 30 to 40 research staff will be among the first priorities for Tasmania's recently-announced $40 million bioinformatics centre of excellence.
ACT feature: ACT biotech's big players
29 May, 2002 by Melissa TrudingerAs one of the big players in the ACT's biotech scene, the John Curtin School of Medical Research (JCSMR) has already spun out at least two companies. Biotron, listed on the ASX, is one, working on two cancer diagnostic tests and a number of therapeutic agents including an antiviral for treatment of HIV.
